We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information on the third and booster doses for people with a weakened immune system.
£16.6 million investment announced today to give semiconductor researchers and businesses access to new equipment helping them test and make chips for use in high-energy machines like electric cars and manufacturing equipment.
The Chancellor has today (4 March) announced a significant investment package in the UK’s life sciences and manufacturing sectors.
Innovative researchers working to tackle some of the hardest-to-treat cancers, including through the use of AI, have received a £2 million funding boost.
The new COVID-19 vaccine from SK Chemicals, has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
This review comments on some improvements in influenza management and promising vaccine development platforms
Projects granted during 2015 that have a primary purpose of basic research: immune system.
The vaccine was approved after it was found to meet the UK regulator's standards of safety, quality and effectiveness
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).